• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估竞争风险下生物标志物的预后准确性。

Evaluating prognostic accuracy of biomarkers under competing risk.

作者信息

Zheng Yingye, Cai Tianxi, Jin Yuying, Feng Ziding

机构信息

Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, Washington 98109, USA.

出版信息

Biometrics. 2012 Jun;68(2):388-96. doi: 10.1111/j.1541-0420.2011.01671.x. Epub 2011 Dec 7.

DOI:10.1111/j.1541-0420.2011.01671.x
PMID:22150576
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3694786/
Abstract

To develop more targeted intervention strategies, an important research goal is to identify markers predictive of clinical events. A crucial step toward this goal is to characterize the clinical performance of a marker for predicting different types of events. In this article, we present statistical methods for evaluating the performance of a prognostic marker in predicting multiple competing events. To capture the potential time-varying predictive performance of the marker and incorporate competing risks, we define time- and cause-specific accuracy summaries by stratifying cases based on causes of failure. Such definition would allow one to evaluate the predictive accuracy of a marker for each type of event and compare its predictiveness across event types. Extending the nonparametric crude cause-specific receiver operating characteristics curve estimators by Saha and Heagerty (2010), we develop inference procedures for a range of cause-specific accuracy summaries. To estimate the accuracy measures and assess how covariates may affect the accuracy of a marker under the competing risk setting, we consider two forms of semiparametric models through the cause-specific hazard framework. These approaches enable a flexible modeling of the relationships between the marker and failure times for each cause, while efficiently accommodating additional covariates. We investigate the asymptotic property of the proposed accuracy estimators and demonstrate the finite sample performance of these estimators through simulation studies. The proposed procedures are illustrated with data from a prostate cancer prognostic study.

摘要

为了制定更具针对性的干预策略,一个重要的研究目标是识别能够预测临床事件的标志物。朝着这个目标迈出的关键一步是描述用于预测不同类型事件的标志物的临床性能。在本文中,我们提出了用于评估预后标志物在预测多个相互竞争事件时性能的统计方法。为了捕捉标志物潜在的随时间变化的预测性能并纳入竞争风险,我们通过根据失败原因对病例进行分层来定义特定时间和特定原因的准确性总结。这样的定义将使人们能够评估标志物对每种类型事件的预测准确性,并比较其在不同事件类型之间的预测能力。通过扩展Saha和Heagerty(2010)提出的非参数粗略特定原因的接收者操作特征曲线估计器,我们开发了一系列特定原因准确性总结的推断程序。为了估计准确性度量并评估协变量在竞争风险设定下如何影响标志物的准确性,我们通过特定原因的风险框架考虑两种形式的半参数模型。这些方法能够灵活地建模标志物与每种原因的失败时间之间的关系,同时有效地纳入其他协变量。我们研究了所提出的准确性估计器的渐近性质,并通过模拟研究展示了这些估计器的有限样本性能。我们用来自前列腺癌预后研究的数据说明了所提出的程序。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ed1/3694786/5a84fc596233/nihms482869f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ed1/3694786/5a84fc596233/nihms482869f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ed1/3694786/5a84fc596233/nihms482869f1.jpg

相似文献

1
Evaluating prognostic accuracy of biomarkers under competing risk.评估竞争风险下生物标志物的预后准确性。
Biometrics. 2012 Jun;68(2):388-96. doi: 10.1111/j.1541-0420.2011.01671.x. Epub 2011 Dec 7.
2
A parametric ROC model-based approach for evaluating the predictiveness of continuous markers in case-control studies.一种基于参数ROC模型的方法,用于评估病例对照研究中连续标志物的预测性。
Biometrics. 2009 Dec;65(4):1133-44. doi: 10.1111/j.1541-0420.2009.01201.x.
3
Assessing risk prediction models in case-control studies using semiparametric and nonparametric methods.应用半参数和非参数方法评估病例对照研究中的风险预测模型。
Stat Med. 2010 Jun 15;29(13):1391-410. doi: 10.1002/sim.3876.
4
Evaluating the predictiveness of a continuous marker.评估连续标志物的预测性。
Biometrics. 2007 Dec;63(4):1181-8. doi: 10.1111/j.1541-0420.2007.00814.x. Epub 2007 May 8.
5
Partial AUC estimation and regression.部分曲线下面积估计与回归
Biometrics. 2003 Sep;59(3):614-23. doi: 10.1111/1541-0420.00071.
6
Choice of prognostic estimators in joint models by estimating differences of expected conditional Kullback-Leibler risks.通过估计期望条件库尔贝克-莱布勒风险的差异来选择联合模型中的预后估计量。
Biometrics. 2012 Jun;68(2):380-7. doi: 10.1111/j.1541-0420.2012.01753.x. Epub 2012 May 11.
7
Quantifying and estimating the predictive accuracy for censored time-to-event data with competing risks.量化和估计具有竞争风险的删失时间事件数据的预测准确性。
Stat Med. 2018 Sep 20;37(21):3106-3124. doi: 10.1002/sim.7806. Epub 2018 May 15.
8
A direct method to evaluate the time-dependent predictive accuracy for biomarkers.一种评估生物标志物时间依赖性预测准确性的直接方法。
Biometrics. 2015 Jun;71(2):439-49. doi: 10.1111/biom.12293. Epub 2015 Mar 10.
9
Semiparametric transformation models for multiple continuous biomarkers in ROC analysis.ROC分析中多个连续生物标志物的半参数转换模型
Biom J. 2015 Sep;57(5):808-33. doi: 10.1002/bimj.201400043. Epub 2015 Jul 3.
10
Inference about time-dependent prognostic accuracy measures in the presence of competing risks.存在竞争风险时的时依预后准确性度量的推断。
BMC Med Res Methodol. 2020 Aug 28;20(1):219. doi: 10.1186/s12874-020-01100-0.

引用本文的文献

1
Accounting for Competing Risks in the Assessment of Prognostic Biomarkers' Discriminative Accuracy.在评估预后生物标志物的判别准确性时考虑竞争风险
Stat Biosci. 2025 Jul 7. doi: 10.1007/s12561-025-09499-0.
2
High risk does not guarantee high accuracy-Evaluating the prognostic accuracy of OCT biomarkers for predicting late AMD.高风险并不保证高准确性——评估光学相干断层扫描生物标志物预测晚期年龄相关性黄斑变性的预后准确性。
Ophthalmic Physiol Opt. 2025 Sep;45(6):1293-1301. doi: 10.1111/opo.13547. Epub 2025 Jun 25.
3
External Validation of the American Heart Association PREVENT Cardiovascular Disease Risk Equations.

本文引用的文献

1
Time-dependent predictive accuracy in the presence of competing risks.存在竞争风险时的时间依赖性预测准确性。
Biometrics. 2010 Dec;66(4):999-1011. doi: 10.1111/j.1541-0420.2009.01375.x.
2
Time-dependent Predictive Values of Prognostic Biomarkers with Failure Time Outcome.具有失败时间结局的预后生物标志物的时间依赖性预测值。
J Am Stat Assoc. 2008;103(481):362-368. doi: 10.1198/016214507000001481.
3
Semiparametric models of time-dependent predictive values of prognostic biomarkers.预后生物标志物时间依赖性预测值的半参数模型
美国心脏协会预防心血管疾病风险方程的外部验证。
JAMA Netw Open. 2024 Oct 1;7(10):e2438311. doi: 10.1001/jamanetworkopen.2024.38311.
4
Differential gene expression analysis pipelines and bioinformatic tools for the identification of specific biomarkers: A review.用于鉴定特定生物标志物的差异基因表达分析流程和生物信息学工具:综述
Comput Struct Biotechnol J. 2024 Mar 1;23:1154-1168. doi: 10.1016/j.csbj.2024.02.018. eCollection 2024 Dec.
5
Addressing subject heterogeneity in time-dependent discrimination for biomarker evaluation.针对生物标志物评估中的时依性判别中的受试个体异质性问题。
Stat Med. 2024 Mar 30;43(7):1341-1353. doi: 10.1002/sim.10024. Epub 2024 Jan 29.
6
Assessing predictive discrimination performance of biomarkers in the presence of treatment-induced dependent censoring.在存在治疗引起的依存性删失的情况下评估生物标志物的预测判别性能。
J R Stat Soc Ser C Appl Stat. 2022 Nov;71(5):1137-1157. doi: 10.1111/rssc.12571. Epub 2022 May 25.
7
Evaluation of competing risks prediction models using polytomous discrimination index.使用多分类判别指数评估竞争风险预测模型。
Can J Stat. 2021 Sep;49(3):731-753. doi: 10.1002/cjs.11583. Epub 2020 Nov 20.
8
Inference about time-dependent prognostic accuracy measures in the presence of competing risks.存在竞争风险时的时依预后准确性度量的推断。
BMC Med Res Methodol. 2020 Aug 28;20(1):219. doi: 10.1186/s12874-020-01100-0.
9
Criteria for evaluating risk prediction of multiple outcomes.评估多种结局风险预测的标准。
Stat Methods Med Res. 2020 Dec;29(12):3492-3510. doi: 10.1177/0962280220929039. Epub 2020 Jun 29.
10
Statistics and measurable residual disease (MRD) testing: uses and abuses in hematopoietic cell transplantation.统计学与可测量残留病(MRD)检测:在造血细胞移植中的应用与滥用
Bone Marrow Transplant. 2020 May;55(5):843-850. doi: 10.1038/s41409-019-0729-4. Epub 2019 Oct 30.
Biometrics. 2010 Mar;66(1):50-60. doi: 10.1111/j.1541-0420.2009.01246.x. Epub 2009 Apr 13.
4
ROC analysis with multiple classes and multiple tests: methodology and its application in microarray studies.多类别和多测试的ROC分析:方法及其在微阵列研究中的应用
Biostatistics. 2008 Jul;9(3):566-76. doi: 10.1093/biostatistics/kxm050. Epub 2008 Feb 27.
5
Evaluating the ROC performance of markers for future events.评估用于预测未来事件的标志物的ROC性能。
Lifetime Data Anal. 2008 Mar;14(1):86-113. doi: 10.1007/s10985-007-9073-x. Epub 2007 Dec 7.
6
Prospective accuracy for longitudinal markers.纵向标记物的前瞻性准确性。
Biometrics. 2007 Jun;63(2):332-41. doi: 10.1111/j.1541-0420.2006.00726.x.
7
Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond.评估新标志物的附加预测能力:从ROC曲线下面积到重新分类及其他。
Stat Med. 2008 Jan 30;27(2):157-72; discussion 207-12. doi: 10.1002/sim.2929.
8
The sensitivity and specificity of markers for event times.事件发生时间标志物的敏感性和特异性。
Biostatistics. 2006 Apr;7(2):182-97. doi: 10.1093/biostatistics/kxi047. Epub 2005 Aug 3.
9
Survival model predictive accuracy and ROC curves.生存模型预测准确性和ROC曲线。
Biometrics. 2005 Mar;61(1):92-105. doi: 10.1111/j.0006-341X.2005.030814.x.
10
Quantifying and comparing the accuracy of binary biomarkers when predicting a failure time outcome.在预测失效时间结局时,对二元生物标志物的准确性进行量化和比较。
Stat Med. 2004 May 30;23(10):1555-70. doi: 10.1002/sim.1747.